Market Cap 9.07M
Revenue (ttm) 0.00
Net Income (ttm) -21.76M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin 0.00%
Debt to Equity Ratio 0.00
Volume 393,000
Avg Vol 599,596
Day's Range N/A - N/A
Shares Out 14.13M
Stochastic %K 9%
Beta 1.56
Analysts Strong Sell
Price Target $9.33

Company Profile

Moleculin Biotech, Inc., a clinical stage pharmaceutical company, focuses on the development of drug candidates for the treatment of cancers and viruses. Its lead drug candidate is Annamycin, which is in Phase 3 clinical trials for the treatment of relapsed or refractory acute myeloid leukemia and in Phase 1B/2 clinical trials for soft tissue sarcoma metastasized to the lungs. The company is also developing a WP1066 portfolio, including WP1066, WP1193, and WP1220, which are immune/transcription...

Industry: Biotechnology
Sector: Healthcare
Phone: (713) 300-5160
Address:
5300 Memorial Drive, Suite 950, Houston, United States
Ff11119
Ff11119 Jun. 16 at 8:46 PM
$MBRX all of the sudden, making it seem organic and respects technical analysis 😄. The more the wait, the more trouble. Take ur time folks. We will see if this is still worth it, given the risks (group of sticks can hurt sometimes)
0 · Reply
Ff11119
Ff11119 Jun. 16 at 4:43 PM
0 · Reply
NEWBIGTECH
NEWBIGTECH Jun. 16 at 2:16 PM
$MBRX Undervalued.
0 · Reply
Ff11119
Ff11119 Jun. 16 at 1:39 PM
$MBRX $MBRX if you have sold at loss, blame this pig below. Armistice Capital suffered their biggest loss in 2025 and in lock up for a year, that's why going nuts with toxic financing and blatant market violations and insider trading. As a gift for them at least, i have created a bot that will send info to SEC, media outlets, influencers etc whenever I flag abnormalities I see, It will stay for the records to years to come and one day, it will hurt them. I won't let them get a way with it, I will later imrpove it to track their 13Gs, and hunt them in every stock their own. I will automate the reporting as well. I will leave it as long as someone will pick it up and charge them. Let them suppressing it even more, so they can hit a case with SEC and it will mark the end of this fraud hudge fund considering their losses.
1 · Reply
Gellener
Gellener Jun. 16 at 11:58 AM
$MBRX next $LGMK ...
0 · Reply
sprinx
sprinx Jun. 15 at 1:45 PM
$MBRX Hopefully we will see Wally (insiders) buying up shares very soon, to trigger this to the upside.
1 · Reply
Blocktatch
Blocktatch Jun. 14 at 8:05 PM
$MBRX I'm in, with 5.000 shares.
0 · Reply
Zdxss1
Zdxss1 Jun. 14 at 1:06 PM
$MBRX Who knows how Cytr affected MBRX? I think it's smart.
0 · Reply
gianpinco
gianpinco Jun. 14 at 1:06 PM
$MBRX you got to own a speculative investment in your portfolio, it's scary because the outcome it's not always what you expect. That said I wish you all and myself good luck 🍀
0 · Reply
jkgyuool
jkgyuool Jun. 14 at 12:06 AM
$MBRX again Crispin is a con artist. Do your due diligence. Leadership should be buying up shares or even releasing a statement that they will give up their bonuses to show confidence in their company. Manipulators and scumbags are driving this stock lower and leadership sits there. They should call a meeting with investors, answer their questions and make a plan on how they’re gonna tackle this BS. Outside of that, I have no confidence in them. Can’t wait to get rid of this investment.
3 · Reply
Latest News on MBRX
Moleculin Biotech, Inc. (MBRX) Q1 2025 Earnings Call Transcript

May 14, 2025, 12:20 PM EDT - 4 weeks ago

Moleculin Biotech, Inc. (MBRX) Q1 2025 Earnings Call Transcript


Moleculin Biotech, Inc. (MBRX) Q4 2024 Earnings Call Transcript

Mar 24, 2025, 10:50 AM EDT - 3 months ago

Moleculin Biotech, Inc. (MBRX) Q4 2024 Earnings Call Transcript


Moleculin to Present at the 37th Annual ROTH Conference

Mar 10, 2025, 8:45 AM EDT - 3 months ago

Moleculin to Present at the 37th Annual ROTH Conference


Moleculin Biotech, Inc. (MBRX) Q3 2024 Earnings Call Transcript

Nov 11, 2024, 11:17 AM EST - 7 months ago

Moleculin Biotech, Inc. (MBRX) Q3 2024 Earnings Call Transcript


Moleculin to Present at Two Upcoming Investor Conferences

Oct 4, 2024, 9:00 AM EDT - 9 months ago

Moleculin to Present at Two Upcoming Investor Conferences


Moleculin Announces Closing of up to $16.5 Million Public Offering

Aug 19, 2024, 4:05 PM EDT - 10 months ago

Moleculin Announces Closing of up to $16.5 Million Public Offering


Moleculin Announces Plans for MIRACLE Phase 3 Pivotal Trial

Aug 1, 2024, 8:30 AM EDT - 11 months ago

Moleculin Announces Plans for MIRACLE Phase 3 Pivotal Trial


Moleculin to Present at the Virtual Investor Pitch Conference

Jun 12, 2024, 9:00 AM EDT - 1 year ago

Moleculin to Present at the Virtual Investor Pitch Conference


Ff11119
Ff11119 Jun. 16 at 8:46 PM
$MBRX all of the sudden, making it seem organic and respects technical analysis 😄. The more the wait, the more trouble. Take ur time folks. We will see if this is still worth it, given the risks (group of sticks can hurt sometimes)
0 · Reply
Ff11119
Ff11119 Jun. 16 at 4:43 PM
0 · Reply
NEWBIGTECH
NEWBIGTECH Jun. 16 at 2:16 PM
$MBRX Undervalued.
0 · Reply
Ff11119
Ff11119 Jun. 16 at 1:39 PM
$MBRX $MBRX if you have sold at loss, blame this pig below. Armistice Capital suffered their biggest loss in 2025 and in lock up for a year, that's why going nuts with toxic financing and blatant market violations and insider trading. As a gift for them at least, i have created a bot that will send info to SEC, media outlets, influencers etc whenever I flag abnormalities I see, It will stay for the records to years to come and one day, it will hurt them. I won't let them get a way with it, I will later imrpove it to track their 13Gs, and hunt them in every stock their own. I will automate the reporting as well. I will leave it as long as someone will pick it up and charge them. Let them suppressing it even more, so they can hit a case with SEC and it will mark the end of this fraud hudge fund considering their losses.
1 · Reply
Gellener
Gellener Jun. 16 at 11:58 AM
$MBRX next $LGMK ...
0 · Reply
sprinx
sprinx Jun. 15 at 1:45 PM
$MBRX Hopefully we will see Wally (insiders) buying up shares very soon, to trigger this to the upside.
1 · Reply
Blocktatch
Blocktatch Jun. 14 at 8:05 PM
$MBRX I'm in, with 5.000 shares.
0 · Reply
Zdxss1
Zdxss1 Jun. 14 at 1:06 PM
$MBRX Who knows how Cytr affected MBRX? I think it's smart.
0 · Reply
gianpinco
gianpinco Jun. 14 at 1:06 PM
$MBRX you got to own a speculative investment in your portfolio, it's scary because the outcome it's not always what you expect. That said I wish you all and myself good luck 🍀
0 · Reply
jkgyuool
jkgyuool Jun. 14 at 12:06 AM
$MBRX again Crispin is a con artist. Do your due diligence. Leadership should be buying up shares or even releasing a statement that they will give up their bonuses to show confidence in their company. Manipulators and scumbags are driving this stock lower and leadership sits there. They should call a meeting with investors, answer their questions and make a plan on how they’re gonna tackle this BS. Outside of that, I have no confidence in them. Can’t wait to get rid of this investment.
3 · Reply
CrisMars
CrisMars Jun. 13 at 11:37 PM
$MBRX market makers are terrific! Again, EVERYBODY who studies this one KNOWS it's a winner for the longs. All of the contrarian crapola spun here is agenda-driven. If ANYONE cannot see the winning potential of this stock they have no business investing on their own.
1 · Reply
NEWBIGTECH
NEWBIGTECH Jun. 13 at 9:28 PM
0 · Reply
NEWBIGTECH
NEWBIGTECH Jun. 13 at 9:27 PM
0 · Reply
NEWBIGTECH
NEWBIGTECH Jun. 13 at 9:17 PM
0 · Reply
NEWBIGTECH
NEWBIGTECH Jun. 13 at 9:16 PM
0 · Reply
NEWBIGTECH
NEWBIGTECH Jun. 13 at 9:13 PM
$MBRX Additionally, the Company is developing WP1066, an Immune/Transcription Modulator capable of inhibiting p-STAT3 and other oncogenic transcription factors while also stimulating a natural immune response, targeting brain tumors, pancreatic and other cancers. Moleculin is also engaged in the development of a portfolio of antimetabolites, including WP1122 for the potential treatment of pathogenic viruses, as well as certain cancer indications.
0 · Reply
NEWBIGTECH
NEWBIGTECH Jun. 13 at 9:03 PM
0 · Reply
NEWBIGTECH
NEWBIGTECH Jun. 13 at 9:03 PM
0 · Reply
NEWBIGTECH
NEWBIGTECH Jun. 13 at 9:01 PM
$MBRX positive topline results from their completed U.S. Phase 1B/2 clinical trial of Annamycin for Soft Tissue Sarcoma Lung Metastases (MB-107). The trial was a multi-center, open-label, single-arm study that determined the Maximum Tolerable Dose and Recommended Phase 2 Dose in Phase 1B, while Phase 2 evaluated Annamycin's efficacy as a monotherapy for STS lung metastases patients eligible for chemotherapy. https://www.stocktitan.net/news/MBRX/moleculin-participates-in-virtual-investor-what-this-means-igkkhag12n4g.html
0 · Reply
IVALTE
IVALTE Jun. 13 at 6:08 PM
0 · Reply
Blocktatch
Blocktatch Jun. 13 at 1:02 PM
$MBRX It is still too early to talk about an RS. There are at least 5 months left for it to happen
0 · Reply
SeanK1998
SeanK1998 Jun. 12 at 3:05 PM
$MBRX are we going into the dirt? Why are there high pt? This looks awful
1 · Reply